About | 瑞普基因

About

About Repu

REPU

Culture

Credential

Leadership

Platform

Partners

REPU

Founded in 2015 by Dr. Ding Lieming, an innovative medicine leader and State Specially Recruited Expert, Repu Technology is a high-tech life health company. Combining precision medicine and AI big data, Repu Technology is the first in China to support innovator drug approvals.

We collaborate closely with renowned pharmaceutical companies, employing AI for drug design and R&D, enhancing research efficiency, and investigating drug efficacy and resistance mechanisms. Simultaneously, we partner with clinical and research institutions to expedite new drug target discovery and early screening and diagnosis tech clinical transformation.

Our mission is to make precision healthcare accessible to everyone. We are committed to leveraging our vast clinical data resources to serve clinical needs, drive clinical translation, and act as a bridge between clinical treatment and new drug development.

Culture

Our Mission

Make Precision Healthcare Accessible to Everyone

Our Vision

Embrace the Role of Pioneers in Digital Precision Healthcare

Our Business Philosophy

R-Reliable
E-Efficient
P-Precise
U-Unique

Our Values

Responsibility，Focus，Innovation，Determination，
Humanity，Synergy

Our Mission

Make Precision Healthcare Accessible to Everyone

Our Vision

Embrace the Role of Pioneers in Digital Precision Healthcare

Our Business Philosophy

R-Reliable
E-Efficient
P-Precise
U-Unique

Our Values

Responsibility，Focus，Innovation，Determination，
Humanity，Synergy

Credential

Repu Technology has consistently excelled in inter-laboratory quality assessments conducted by renowned domestic and international organizations, including CAP and NCCL. This reaffirms RepuGene's strong technical capabilities, meticulous operational procedures, and superior product design in the field of tumor gene testing. It also signifies Repugene Medical Testing Laboratory's inclusion among top-tier international medical testing facilities, with recognized standards of quality management, technical proficiency, and precision in biological data analysis.

Leadership

Executive Team

Consultant Team

Dr. Ding Lieming

Founder and Chairman

Ms. Lou Shengqiong

Founder and CEO

Mr. Zheng Xiang

Director of Production

Dr. Zhou Yan

Director of Strategic Development

Dr. Wang Yang

Director of R&D

Dr. Meng Yiran

R&D Scientist

Dr. Zhang Mingming

Director of Digital Engineering

Ms. Guo Lixia

Director of Marketing

Dr. Jia Lei

Manager of Clinical Bioinformatics

Dr. Song Ruilin

Expert Committee Members

Mr. Wan Jiang

Expert Committee Members

Prof. Sun Wenyong

Expert Committee Members

Prof. Shen Yiping

Expert Committee Members

Platform

Repu Technology has established a diversified hardware platform, which includes sequencing platforms equipped with Illumina Nova6000, X Ten, HiSeq4000, and MGISeq-2000, MGISeq-200, and other leading sequencers. These platforms offer robust sequencing throughput and flexible sequencing cycles. Our single-cell spatial omics platform is equipped with 10X Genomics Chromium Controller, Chromium X, Visium CytAssist, and related facilities. We were one of the first companies in the East China region to introduce a complete set of 10X single-cell instruments.

Partners

Companies

Hospitals

Institutions

Repu Technology has established collaborations with domestic healthcare and educational institutions in China. Their research spans joint drug studies, tumor staging mechanisms, comparative genomics of patients at different stages, and drug efficacy. They've also partnered with pharmaceutical companies, notably Betta Pharmaceuticals, for tumor biomarker selection, clinical trials, efficacy monitoring, and companion diagnostics. Additionally, they've collaborated with Wenzhou Medical University to establish the "Wenzhou Medical University Institute of Pharmacogenomics Research" ，and have a strategic partnership with the Zhejiang Provincial Lung Cancer Diagnosis and Treatment.